{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-060805","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2024-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.651233+00:00","generated_at":"2026-06-01T21:41:12.900384+00:00","sec_items":["1.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MiNK Therapeutics raises ~$5.8M via 4.64M shares at $1.25/share, 25% premium to VWAP","bullets":["Issued 4,640,000 common shares at $1.25 per share, a 25% premium to 30-day VWAP.","Net proceeds of approximately $5.8 million after offering expenses.","Transaction closed on May 14, 2024.","Registration statement due by Aug 15, 2024; investor locked up until Nov 9, 2024.","Investor agrees to vote shares in line with board recommendation through May 14, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-060805","json":"https://secwatch.observer/filing/0000950170-24-060805.json","markdown":"https://secwatch.observer/filing/0000950170-24-060805.md","text":"https://secwatch.observer/filing/0000950170-24-060805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024060805/0000950170-24-060805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024060805/inkt-20240513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T21:41:12.900384+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}